BPMC
Alyeska Investment Group’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-50,000
| Closed | -$4.43M | – | 570 |
|
|
2025
Q1 | $4.43M | Buy |
+50,000
| New | +$4.43M | 0.02% | 366 |
|
|
2020
Q3 | – | Sell |
-296,858
| Closed | -$23.2M | – | 470 |
|
|
2020
Q2 | $23.2M | Buy |
296,858
+95,124
| +47% | +$7.42M | 0.35% | 101 |
|
|
2020
Q1 | $11.8M | Buy |
201,734
+161,482
| +401% | +$9.44M | 0.23% | 116 |
|
|
2019
Q4 | $3.23M | Buy |
+40,252
| New | +$3.23M | 0.04% | 244 |
|
|
2019
Q2 | – | Sell |
-169,505
| Closed | -$13.6M | – | 401 |
|
|
2019
Q1 | $13.6M | Buy |
+169,505
| New | +$13.6M | 0.18% | 140 |
|
|
2018
Q3 | – | Sell |
-119,758
| Closed | -$7.6M | – | 376 |
|
|
2018
Q2 | $7.6M | Buy |
119,758
+45,602
| +61% | +$2.89M | 0.07% | 230 |
|
|
2018
Q1 | $6.8M | Buy |
74,156
+3,665
| +5% | +$336K | 0.06% | 244 |
|
|
2017
Q4 | $5.32M | Sell |
70,491
-29,509
| -30% | -$2.23M | 0.04% | 239 |
|
|
2017
Q3 | $6.97M | Buy |
+100,000
| New | +$6.97M | 0.05% | 252 |
|
|
2017
Q2 | – | Sell |
-59,746
| Closed | -$2.39M | – | 431 |
|
|
2017
Q1 | $2.39M | Sell |
59,746
-40,254
| -40% | -$1.61M | 0.02% | 372 |
|
|
2016
Q4 | $2.81M | Buy |
+100,000
| New | +$2.81M | 0.02% | 362 |
|
|
2016
Q3 | – | Sell |
-183,740
| Closed | -$3.72M | – | 442 |
|
|
2016
Q2 | $3.72M | Buy |
183,740
+91,903
| +100% | +$1.86M | 0.04% | 320 |
|
|
2016
Q1 | $1.66M | Buy |
91,837
+17,556
| +24% | +$317K | 0.02% | 335 |
|
|
2015
Q4 | $1.96M | Sell |
74,281
-9,633
| -11% | -$254K | 0.02% | 303 |
|
|
2015
Q3 | $1.79M | Buy |
83,914
+7,679
| +10% | +$164K | 0.02% | 334 |
|
|
2015
Q2 | $2.02M | Buy |
+76,235
| New | +$2.02M | 0.02% | 330 |
|